Bayer Aktiengesellschaft Stock Forecast, Price & News

-0.27 (-1.78 %)
(As of 07/30/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume337,719 shs
Average Volume297,070 shs
Market Capitalization$58.40 billion
P/E RatioN/A
Dividend Yield2.74%
30 days | 90 days | 365 days | Advanced Chart
Receive BAYRY News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

Bayer Aktiengesellschaft logo

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc. and Forschungszentrum Jülich GmbH; strategic research partnership with University of Oxford to develop novel gynecological therapies; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value





Social Links


Overall MarketRank

1.37 out of 5 stars

Medical Sector

1069th out of 2,219 stocks

Pharmaceutical Preparations Industry

508th out of 869 stocks

Analyst Opinion: 0.0Community Rank: 3.1Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Frequently Asked Questions

Is Bayer Aktiengesellschaft a buy right now?

17 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bayer Aktiengesellschaft in the last year. There are currently 8 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Bayer Aktiengesellschaft stock.
View analyst ratings for Bayer Aktiengesellschaft
or view top-rated stocks.

What stocks does MarketBeat like better than Bayer Aktiengesellschaft?

Wall Street analysts have given Bayer Aktiengesellschaft a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Bayer Aktiengesellschaft wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Bayer Aktiengesellschaft?

Bayer Aktiengesellschaft saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 100,900 shares, an increase of 34.2% from the June 30th total of 75,200 shares. Based on an average daily volume of 580,400 shares, the days-to-cover ratio is currently 0.2 days.
View Bayer Aktiengesellschaft's Short Interest

When is Bayer Aktiengesellschaft's next earnings date?

Bayer Aktiengesellschaft is scheduled to release its next quarterly earnings announcement on Tuesday, August 3rd 2021.
View our earnings forecast for Bayer Aktiengesellschaft

How were Bayer Aktiengesellschaft's earnings last quarter?

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) released its quarterly earnings results on Wednesday, May, 12th. The company reported $0.78 EPS for the quarter, beating the consensus estimate of $0.71 by $0.07. The company earned $14.86 billion during the quarter, compared to analyst estimates of $14.43 billion. Bayer Aktiengesellschaft had a positive trailing twelve-month return on equity of 18.95% and a negative net margin of 22.67%.
View Bayer Aktiengesellschaft's earnings history

How has Bayer Aktiengesellschaft's stock been impacted by Coronavirus (COVID-19)?

Bayer Aktiengesellschaft's stock was trading at $16.58 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BAYRY shares have decreased by 10.4% and is now trading at $14.86.
View which stocks have been most impacted by COVID-19

How often does Bayer Aktiengesellschaft pay dividends? What is the dividend yield for Bayer Aktiengesellschaft?

Bayer Aktiengesellschaft declared a dividend on Saturday, April 17th. Investors of record on Thursday, April 29th will be given a dividend of $1.3563 per share on Monday, May 10th. This represents a dividend yield of 8.55%. The ex-dividend date is Wednesday, April 28th.
View Bayer Aktiengesellschaft's dividend history

Is Bayer Aktiengesellschaft a good dividend stock?

Bayer Aktiengesellschaft pays an annual dividend of $0.41 per share and currently has a dividend yield of 2.74%. The dividend payout ratio of Bayer Aktiengesellschaft is 22.53%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Bayer Aktiengesellschaft will have a dividend payout ratio of 20.10% next year. This indicates that Bayer Aktiengesellschaft will be able to sustain or increase its dividend.
View Bayer Aktiengesellschaft's dividend history.

Who are Bayer Aktiengesellschaft's key executives?

Bayer Aktiengesellschaft's management team includes the following people:
  • Mr. Werner Baumann, Chairman of Management Board, CEO & Chief Sustainability Officer (Age 59, Pay $6.41M)
  • Mr. Wolfgang U. Nickl, CFO & Member of Management Board (Age 52, Pay $2.35M)
  • Mr. Liam Condon, Member of Management Board & Pres Crop Science Division (Age 53, Pay $3.24M)
  • Mr. Heiko W. J. Schipper, Member of Management Board & Pres of the Consumer Health Division (Age 52, Pay $2.95M)
  • Mr. Stefan Oelrich, Head of the Pharmaceuticals Division & Member of the Board of Management (Age 53, Pay $3.43M)
  • Ms. Sarena S. Lin, Chief Transformation & Talent Officer, Labor Director and Member of Management Board (Age 50)
  • Mr. Bernd-Peter Bier, Head of Accounting and Head of Taxes (Age 54)
  • Mr. Oliver Maier, Head of Investor Relations
  • Dr. Gabriel Harnier, Head of Law, Patents & Compliance (Age 50)
  • Mr. Michael Preuss, Head of Communications, Gov. Relations and Corp. Brand

Who are some of Bayer Aktiengesellschaft's key competitors?

What is Bayer Aktiengesellschaft's stock symbol?

Bayer Aktiengesellschaft trades on the OTCMKTS under the ticker symbol "BAYRY."

How do I buy shares of Bayer Aktiengesellschaft?

Shares of BAYRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bayer Aktiengesellschaft's stock price today?

One share of BAYRY stock can currently be purchased for approximately $14.86.

How much money does Bayer Aktiengesellschaft make?

Bayer Aktiengesellschaft has a market capitalization of $58.40 billion and generates $47.29 billion in revenue each year. The company earns $-11,988,440,000.00 in net income (profit) each year or $1.82 on an earnings per share basis.

How many employees does Bayer Aktiengesellschaft have?

Bayer Aktiengesellschaft employs 99,538 workers across the globe.

Does Bayer Aktiengesellschaft have any subsidiaries?

The following companies are subsidiares of Bayer Aktiengesellschaft: AB Seeds Ltd, AB Seeds Sales (2006) Ltd, AO Bayer, Adverio Pharma GmbH, AgrEvo Verwaltungsgesellschaft mbH, AgraQuest Inc., Alcafleu Management GmbH & Co. KG, Algeta, Artificial Muscle Inc, Asklepios BioPharmaceutical, Athenix Corp., Atlantic Breeders S. A. R. L., BUS C.V., Bayer (Proprietary) Limited, Bayer (Schweiz) AG, Bayer 04 Immobilien GmbH, Bayer 04 Leverkusen Fußball GmbH, Bayer A / S, Bayer AB, Bayer AS, Bayer Agriculture BVBA, Bayer Agriculture Limited, Bayer Algerie S. P. A., Bayer Altersversorgung GmbH, Bayer Animal Health GmbH, Bayer Austria Gesellschaft m.b.H., Bayer B.V., Bayer Beteiligungsverwaltung Goslar GmbH, Bayer Beteiligungsverwaltungsgesellschaft mbH & Co. OHG, Bayer Bitterfeld GmbH, Bayer Bulgaria EOOD, Bayer Business Services GmbH, Bayer Canadian Holdings Inc., Bayer Capital Corporation B.V., Bayer Chemicals GmbH, Bayer Consumer Care AG, Bayer Consumer Care Holdings LLC, Bayer Corporation, Bayer CropScience, Bayer CropScience (Portugal)-Produtos para a Agricultura Lda, Bayer CropScience Beteiligungsgesellschaft mit beschränkter Haftung, Bayer CropScience Biologics GmbH, Bayer CropScience Deutschland GmbH, Bayer CropScience Holding Inc., Bayer CropScience Holding SA, Bayer CropScience Holdings Inc., Bayer CropScience Inc., Bayer CropScience LLC, Bayer CropScience LP, Bayer CropScience Limited, Bayer CropScience NV, Bayer CropScience S. L., Bayer CropScience S. r. l., Bayer CropScience Schweiz AG, Bayer CropScience Vermögensverwaltungsgesellschaft mbH, Bayer East Coast LLC, Bayer Essure Inc., Bayer HealthCare Animal Health Inc., Bayer HealthCare Holdings LLC, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare US Funding II LLC, Bayer HealthCare US Funding LLC, Bayer Inc., Bayer International Trade Services Corporation, Bayer Medical Care Inc., Bayer New AU M1059 USD LLC, Bayer New AU M3650 LLC, Bayer New BE M3155 LLC, Bayer New CA M5015 LLC, Bayer New CH M3868 LLC, Bayer New CZ M3204 LLC, Bayer New DE M3385 LLC, Bayer New Gewas I M3640 LLC, Bayer New Gewas II M3640 LLC, Bayer New HU M3440 LLC, Bayer New MA M3130 LLC, Bayer New MX M3640 LLC, Bayer New MY M1455 LLC, Bayer New NL M3644 LLC, Bayer New Oogst M3648 LLC, Bayer New PL M3655 LLC, Bayer New RO M3695 LLC, Bayer New RU M3708 LLC, Bayer New TH M1763 LLC, Bayer New TK M3970 LLC, Bayer New UA M3702 LLC, Bayer New UK M3939 LLC, Bayer New Veggie M3617 M5157 LLC, Bayer New Veggie Mig M3617 M5157 LLC, Bayer New ZA M3743 LLC, Bayer Overseas Trade Services Corporation, Bayer Puerto Rico Inc., Bayer U.S. LLC, Bayer US Finance II LLC, Bayer US Finance LLC, Bayer US Holding LP, Bayer West Coast Corporation, Bayer World Investments B.V., Bayer d. o. o., Bayer spol. sr. o., Bayer-Handelsgesellschaft mit beschränkter Haftung, Beeologics Admin LLC, Beeologics Holdings Limited, Beeologics LLC, Beeologics USA Inc, Berlimed S. A., Berlipharm B.V., Berlis AG, Biogenetic Technologies B.V., BlueRock Therapeutics, Care/of, Channel Bio LLC, Chemion Logistik GmbH, Collateral Therapeutics Inc., Conceptus SAS La Garenne, Cooper Land Company of New Jersey Inc., Coppertone LLC, Corn States LLC, Dihon Pharmaceutical, Dr. Scholl’s LLC, Dritte Bayer Real Estate VV GmbH & Co. KG, Erste Bayer Real Estate VV GmbH & Co. KG, Erste K-W-A Beteiligungsgesellschaft mbH, EuroServices Bayer S. L., Fünfte Bayer Real Estate VV GmbH & Co., GP Grenzach Produktions GmbH, Grass Roots Biotechnology LLC, Hornbeck Seed Company Inc., Icon Genetics, Intendis GmbH, Intraserv GmbH & Co., Jenapharm GmbH & Co. KG, KVP Pharma+Veterinär Produkte GmbH, KWA Investment II LLC Research, KWA Investment III LLC, KWA Investment IV LLC, KaNDy Therapeutics, MENADIER Heilmittel GmbH, MNL Luxembourg S. a. r. l., MONSANTO Hungaria Kft., MONSANTO Saaten GmbH, Merck-Consumer Care (MCC), MiraLAX LLC, Monsanto ACUA MHC LLC, Monsanto AG Netherlands I C.V., Monsanto AG Netherlands II C.V., Monsanto AGN Holding LLC, Monsanto Ag B.V., Monsanto Agrar Deutschland GmbH, Monsanto Agricultura España S. L., Monsanto Agricultura Italia S.p.A., Monsanto Agriculture Nigeria Limited, Monsanto Burkina Faso SARL, Monsanto CR s. r. o., Monsanto Canada ULC, Monsanto Caribe LLC, Monsanto Company, Monsanto Crop B.V., Monsanto Crop Sciences Denmark A/S, Monsanto Crop Sciences Norway A/S, Monsanto Crop Sciences Sweden A.B., Monsanto Finance SA, Monsanto Gesellschaft m. b. H., Monsanto Gida Ve Tarim Ticaret Ltd, Monsanto Grain B.V., Monsanto Great Lakes Production Co LLC, Monsanto Hawaii Production Co LLC, Monsanto Hellas Agriculturals Ltd, Monsanto Holding I C.V., Monsanto Holding II C.V., Monsanto Holding III C.V., Monsanto Holding Ukraine Ltd, Monsanto Holland B.V., Monsanto II Lda, Monsanto Illinois Production Co LLC, Monsanto Inter-America Company, Monsanto International Sarl, Monsanto Invest B.V., Monsanto Iowa Production Co LLC, Monsanto Ireland Limited, Monsanto Jordan LLC, Monsanto Kenya Ltd, Monsanto Kool BV, Monsanto LA Holdings II Co LLC, Monsanto Latin America Holdings Co LLC, Monsanto MGCV MHC LLC, Monsanto MSCV Holding LLC, Monsanto MYCV MHC LLC, Monsanto Malawi Ltd, Monsanto Missouri Production Co LLC, Monsanto NL BV, Monsanto Northern Production Co LLC, Monsanto Oogst B.V., Monsanto Operations B.V., Monsanto Polska Sp. z o. o., Monsanto Production Supply LLC, Monsanto Romania SRL, Monsanto Rus LLC, Monsanto S.A.S., Monsanto Seed Supply LLC, Monsanto Seeds LLC, Monsanto Serbia D. O. O., Monsanto Slovakia S. R. O., Monsanto South Africa (PTY) Ltd, Monsanto Southern Production Co LLC, Monsanto Tanzania Limited, Monsanto Technology International LLC, Monsanto Technology LLC, Monsanto Treasury Services SARL, Monsanto UK Limited Cambridge U. K., Monsanto Vegetable Holding LLC, Monsanto Vegetable IP Holding C.V., Monsanto Vegetable IP Management BV, Monsanto Vegetable Seed Holding LLC, Monsanto Western Production Co LLC, Monsanto Zaad B.V., Monsanto Zambia Ltd, Monsanto d. o. o., Pallas Versicherung, Pandias Re AG, Pianosa B.V., Relay Limited, SC Bayer SRL, SCEA De Ruiter Zonen Selection, Sechste Bayer Real Estate VV GmbH & Co., Seminis Vegetable Seeds U. K. Ltd, Siebte Bayer VV GmbH, Steigerwald Arzneimittelwerk GmbH, TECTRION GmbH, TOO Bayer KAZ, The Climate Corporation International SA, TravelBoard GmbH, UAB Bayer, Vierte Bayer Real Estate VV GmbH & Co., WeatherMe OÜ, Zeptosens, Zoner.ag, Zweite Bayer Real Estate VV GmbH & Co., and Zweite K-W-A Beteiligungsgesellschaft mbH.

When was Bayer Aktiengesellschaft founded?

Bayer Aktiengesellschaft was founded in 1863.

What is Bayer Aktiengesellschaft's official website?

The official website for Bayer Aktiengesellschaft is www.bayer.com.

Where are Bayer Aktiengesellschaft's headquarters?

Bayer Aktiengesellschaft is headquartered at Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368.

How can I contact Bayer Aktiengesellschaft?

Bayer Aktiengesellschaft's mailing address is Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368. The company can be reached via phone at 49-21-4-30-1 or via email at [email protected]

This page was last updated on 7/31/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.